Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. C. Lev
Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
Neo-Adjuvant Chemotherapy Alone or With Regional Hyperthermia for Soft-Tissue Sarcoma
The Lancet Oncology
Oncology
Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma
Nowotwory
Cancer Research
Oncology
New Drugs and Combinations for the Treatment of Soft-Tissue Sarcoma: A Review
Cancer Management and Research
Oncology
Treatment of Pelvic Bone and Soft Tissue Sarcoma.
Orthopedics & Traumatology
Role of Trabectedin in the Treatment of Soft Tissue Sarcoma
OncoTargets and Therapy
Oncology
Pharmacology
Epigenetic Modulation With Oral Histone Deacetylase (HDAC) Inhibitor as a New Treatment Option in JIA
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology